Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) Other Operating Expenses: 2010-2025

Historic Other Operating Expenses for Mesa Laboratories (MLAB) over the last 15 years, with Sep 2025 value amounting to $9.8 million.

  • Mesa Laboratories' Other Operating Expenses fell 0.54% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.4 million, marking a year-over-year decrease of 86.50%. This contributed to the annual value of $41.7 million for FY2025, which is 86.69% down from last year.
  • As of Q3 2025, Mesa Laboratories' Other Operating Expenses stood at $9.8 million, which was down 10.40% from $10.9 million recorded in Q2 2025.
  • In the past 5 years, Mesa Laboratories' Other Operating Expenses ranged from a high of $284.8 million in Q1 2024 and a low of -$8.4 million during Q4 2021.
  • In the last 3 years, Mesa Laboratories' Other Operating Expenses had a median value of $9.8 million in 2024 and averaged $35.0 million.
  • As far as peak fluctuations go, Mesa Laboratories' Other Operating Expenses slumped by 392.17% in 2021, and later surged by 2,812.31% in 2024.
  • Over the past 5 years, Mesa Laboratories' Other Operating Expenses (Quarterly) stood at -$8.4 million in 2021, then soared by 106.62% to $558,000 in 2022, then surged by 1,644.98% to $9.7 million in 2023, then increased by 7.32% to $10.4 million in 2024, then dropped by 0.54% to $9.8 million in 2025.
  • Its last three reported values are $9.8 million in Q3 2025, $10.9 million for Q2 2025, and $11.3 million during Q1 2025.